Update on Clinical Trial: I started 2nd... - SHARE Metastatic ...

SHARE Metastatic Breast Cancer

6,607 members8,142 posts

Update on Clinical Trial

Trissh profile image
8 Replies

I started 2nd line treatment about 9 weeks ago here in Charlotte. It is a clinical trial for ER+, Her2- with pik3ca mutation. Drugs are Inavolisib and Giredestrant (SERD). First scans last week were stable, with tiny bit of shrinkage... cautiously optimistic. Side effects not bad.

Written by
Trissh profile image
Trissh
To view profiles and participate in discussions please or .
Read more about...
8 Replies
NPmary profile image
NPmary

I hope you have sustained good reports for a very long time.

HelenWi profile image
HelenWi

Stable and shrinkage are good words! Hope it continues !

Nocillo profile image
Nocillo

Hope it continues to go well. I used to go to Levine there in Charlotte.

Jhshl512 profile image
Jhshl512

This is positive feedback. Wonderful for you! Please keep us posted!🙏🏻

13plus profile image
13plus

I hope for you that it’s a great success! Sounds like you’re off to a great start :)

RachH20 profile image
RachH20

sounds great, glad to hear you have had a stable scan, I have same mutation and subtype, really interesting to hear from you about this, keep us posted. Glad the side effects are manageable x

Dragonfly2 profile image
Dragonfly2

best wishes for continued success!

kickaliz profile image
kickaliz

Stay positive and keep us updated. You are blessed.

You may also like...

Clinical trial update

am ER+, HER2 low +1, PR-, AR+, with pik3ca and TP53 mutations. This trial addresses the Pik3ca and...

VIKTORIA-1 CLINICAL TRIAL

I will know more after scans next week. If not, are you on a clinical trial? I’m feeling like it’s...

Clinical Trials

found a clinical trial for me! So far it has cut my tumor marker in half! The side effects are...

Exelixis Clinical trial XL091 pill and Tecentriq (Atezolizumab)

advanced breast cancer er/pr+, her2 neg, asked to do this trial? I am a bit concerned because I was...

IMMU-132 Clinical trial

Tomorrow I begin a clinical trial for triple negative breast cancer. This trial has been showing...